|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00455 TIANDA PHARMA
Nominal 
0.000 (0.000%) | 2024/12 - Final HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2022/03 HKD(K$) | 2021/03 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | (9,698) | (49,757) | 76,428 | (8,225) | (37,635) |
| Net Cash from / (used in) Investing Activities | (31,775) | (69,101) | (9,608) | 86,350 | (137,733) |
| Net Cash from / (used in) Financing Activities | (30,649) | (57,394) | (28,890) | (1,295) | 90,753 |
| Increase / (Decrease) in Cash & Cash Equivalents | (72,122) | (176,252) | 37,930 | 76,830 | (84,614) |
| Cash & Cash Equivalents at beginning of period | 162,442 | 340,277 | 334,002 | 248,247 | 311,963 |
| Effect of Foreign Exchange Rate Changes | (4,632) | (1,583) | (31,655) | 8,925 | 20,899 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | 85,688 | 162,442 | 340,277 | 334,002 | 248,247 |
| Remarks: | Real time quote last updated: 23/07/2025 07:44 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -61,371 |
| %Change | 154.072% |
| EPS / (LPS) | HKD -0.029 |
| NBV Per Share ($) | HKD 0.235 |